CinCor Pharma, Inc.
(NASDAQ) CINC
CinCor Pharma, Inc. Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$93.31M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CINC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CinCor Pharma, Inc.
Industry
Pharmaceuticals
Sector
Health CareEmployees
15
CEO
Marc M. P. de Garidel, EMBA
Website
cincor.comHeadquarters
Boston, MA 02116, US
CINC Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
1%
Return on Capital
-34%
Return on Assets
-36%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$42.51M
EBITDA
$34.63M
Operating Cash Flow
$30.85M
Capital Expenditure
$0.00
Free Cash Flow
$30.85M
Cash & ST Invst.
$136.61M
Total Debt
$0.00
CinCor Pharma, Inc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
19
N/A
Net Income
$19.71M
-118.4%
EBITDA
$19.71M
-118.4%
Quarterly Fundamentals
Net Cash
$522.50M
+268.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-35.68%
N/A
Return on Invested Capital
-34.13%
N/A
Free Cash Flow
$15.18M
-143.3%
Operating Cash Flow
$15.11M
-142.2%